Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

An observational analysis finds the drugs may lower the risk of substance abuse and cognitive issues. But the findings need ...

Game-changing weight loss jabs relied on by millions of slimmers ... In 2023, research on mice and rats suggested semaglutide — the powerful ingredient behind Wegovy and Ozempic — could ...

THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...

Of late, there have been many questions about maintaining weight loss after using Ozempic (semaglutide) and whether the process kick-started by the drug can be sustainable in the long run. Ozempic ...

Topiramate, primarily used for epilepsy and migraine prevention, is emerging as a cost-effective treatment for weight loss compared to high-cost drugs like Ozempic. A study showed significant ...

Semaglutide injections, like Ozempic and Wegovy, are approved to treat type 2 diabetes. However, many individuals without diabetes also use them off-label for weight loss. And while highly ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has approved Novo Nordisk’s semaglutide for heart disease and Eli Lilly’s ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse ...